These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

414 related items for PubMed ID: 22547442

  • 1. Aldosterone inhibits antifibrotic factors in mouse hypertensive heart.
    Azibani F, Benard L, Schlossarek S, Merval R, Tournoux F, Fazal L, Polidano E, Launay JM, Carrier L, Chatziantoniou C, Samuel JL, Delcayre C.
    Hypertension; 2012 Jun; 59(6):1179-87. PubMed ID: 22547442
    [Abstract] [Full Text] [Related]

  • 2. Eplerenone attenuates myocardial fibrosis in the angiotensin II-induced hypertensive mouse: involvement of tenascin-C induced by aldosterone-mediated inflammation.
    Nishioka T, Suzuki M, Onishi K, Takakura N, Inada H, Yoshida T, Hiroe M, Imanaka-Yoshida K.
    J Cardiovasc Pharmacol; 2007 May; 49(5):261-8. PubMed ID: 17513943
    [Abstract] [Full Text] [Related]

  • 3. [Hypertension-induced fibrosis: a balance story].
    Azibani F, Fazal L, Chatziantoniou C, Samuel JL, Delcayre C.
    Ann Cardiol Angeiol (Paris); 2012 Jun; 61(3):150-5. PubMed ID: 22681982
    [Abstract] [Full Text] [Related]

  • 4. Galectin-3 blockade inhibits cardiac inflammation and fibrosis in experimental hyperaldosteronism and hypertension.
    Martínez-Martínez E, Calvier L, Fernández-Celis A, Rousseau E, Jurado-López R, Rossoni LV, Jaisser F, Zannad F, Rossignol P, Cachofeiro V, López-Andrés N.
    Hypertension; 2015 Oct; 66(4):767-75. PubMed ID: 26238446
    [Abstract] [Full Text] [Related]

  • 5. Aldosterone inhibits the fetal program and increases hypertrophy in the heart of hypertensive mice.
    Azibani F, Devaux Y, Coutance G, Schlossarek S, Polidano E, Fazal L, Merval R, Carrier L, Solal AC, Chatziantoniou C, Launay JM, Samuel JL, Delcayre C.
    PLoS One; 2012 Oct; 7(5):e38197. PubMed ID: 22666483
    [Abstract] [Full Text] [Related]

  • 6. The antagonism of aldosterone receptor prevents the development of hypertensive heart failure induced by chronic inhibition of nitric oxide synthesis in rats.
    Tsukamoto O, Minamino T, Sanada S, Okada K, Hirata A, Fujita M, Shintani Y, Yulin L, Asano Y, Takashima S, Yamasaki S, Tomoike H, Hori M, Kitakaze M.
    Cardiovasc Drugs Ther; 2006 Apr; 20(2):93-102. PubMed ID: 16761190
    [Abstract] [Full Text] [Related]

  • 7. A role for cardiotrophin-1 in myocardial remodeling induced by aldosterone.
    López-Andrés N, Martin-Fernandez B, Rossignol P, Zannad F, Lahera V, Fortuno MA, Cachofeiro V, Díez J.
    Am J Physiol Heart Circ Physiol; 2011 Dec; 301(6):H2372-82. PubMed ID: 21926338
    [Abstract] [Full Text] [Related]

  • 8. Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats.
    Takeda Y, Zhu A, Yoneda T, Usukura M, Takata H, Yamagishi M.
    Am J Hypertens; 2007 Oct; 20(10):1119-24. PubMed ID: 17903697
    [Abstract] [Full Text] [Related]

  • 9. Atrial natriuretic peptide locally counteracts the deleterious effects of cardiomyocyte mineralocorticoid receptor activation.
    Nakagawa H, Oberwinkler H, Nikolaev VO, Gaßner B, Umbenhauer S, Wagner H, Saito Y, Baba HA, Frantz S, Kuhn M.
    Circ Heart Fail; 2014 Sep; 7(5):814-21. PubMed ID: 25027872
    [Abstract] [Full Text] [Related]

  • 10. Blockade of PAR-1 Signaling Attenuates Cardiac Hypertrophy and Fibrosis in Renin-Overexpressing Hypertensive Mice.
    Yokono Y, Hanada K, Narita M, Tatara Y, Kawamura Y, Miura N, Kitayama K, Nakata M, Nozaka M, Kato T, Kudo N, Tsushima M, Toyama Y, Itoh K, Tomita H.
    J Am Heart Assoc; 2020 Jun 16; 9(12):e015616. PubMed ID: 32495720
    [Abstract] [Full Text] [Related]

  • 11. Deficiency of T-type Ca2+ channels Cav3.1 and Cav3.2 has no effect on angiotensin II-induced hypertension but differential effect on plasma aldosterone in mice.
    Thuesen AD, Finsen SH, Rasmussen LL, Andersen DC, Jensen BL, Hansen PBL.
    Am J Physiol Renal Physiol; 2019 Aug 01; 317(2):F254-F263. PubMed ID: 31042060
    [Abstract] [Full Text] [Related]

  • 12. Aldosterone deficiency and mineralocorticoid receptor antagonism prevent angiotensin II-induced cardiac, renal, and vascular injury.
    Luther JM, Luo P, Wang Z, Cohen SE, Kim HS, Fogo AB, Brown NJ.
    Kidney Int; 2012 Sep 01; 82(6):643-51. PubMed ID: 22622494
    [Abstract] [Full Text] [Related]

  • 13. Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats.
    Nagata K, Obata K, Xu J, Ichihara S, Noda A, Kimata H, Kato T, Izawa H, Murohara T, Yokota M.
    Hypertension; 2006 Apr 01; 47(4):656-64. PubMed ID: 16505208
    [Abstract] [Full Text] [Related]

  • 14. Cardiac aldosterone production in genetically hypertensive rats.
    Takeda Y, Yoneda T, Demura M, Miyamori I, Mabuchi H.
    Hypertension; 2000 Oct 01; 36(4):495-500. PubMed ID: 11040225
    [Abstract] [Full Text] [Related]

  • 15. Cardiac-deleterious role of galectin-3 in chronic angiotensin II-induced hypertension.
    González GE, Rhaleb NE, D'Ambrosio MA, Nakagawa P, Liao TD, Peterson EL, Leung P, Dai X, Janic B, Liu YH, Yang XP, Carretero OA.
    Am J Physiol Heart Circ Physiol; 2016 Nov 01; 311(5):H1287-H1296. PubMed ID: 27496875
    [Abstract] [Full Text] [Related]

  • 16. Role of Rho kinase and oxidative stress in cardiac fibrosis induced by aldosterone and salt in angiotensin type 1a receptor knockout mice.
    Kagiyama S, Matsumura K, Goto K, Otsubo T, Iida M.
    Regul Pept; 2010 Feb 25; 160(1-3):133-9. PubMed ID: 19969025
    [Abstract] [Full Text] [Related]

  • 17. Severe hyperaldosteronism in neonatal Task3 potassium channel knockout mice is associated with activation of the intraadrenal renin-angiotensin system.
    Bandulik S, Tauber P, Penton D, Schweda F, Tegtmeier I, Sterner C, Lalli E, Lesage F, Hartmann M, Barhanin J, Warth R.
    Endocrinology; 2013 Aug 25; 154(8):2712-22. PubMed ID: 23698720
    [Abstract] [Full Text] [Related]

  • 18. This is not Dr. Conn's aldosterone anymore.
    Brown NJ.
    Trans Am Clin Climatol Assoc; 2011 Aug 25; 122():229-43. PubMed ID: 21686229
    [Abstract] [Full Text] [Related]

  • 19. Eplerenone prevents adverse cardiac remodelling induced by pressure overload in atrial natriuretic peptide-null mice.
    Franco V, Chen YF, Feng JA, Li P, Wang D, Hasan E, Oparil S, Perry GJ.
    Clin Exp Pharmacol Physiol; 2006 Sep 25; 33(9):773-9. PubMed ID: 16922805
    [Abstract] [Full Text] [Related]

  • 20. Spironolactone alleviates late cardiac remodeling after left ventricular restoration surgery.
    Tsukashita M, Marui A, Nishina T, Yoshikawa E, Kanemitsu H, Wang J, Ikeda T, Komeda M.
    J Thorac Cardiovasc Surg; 2008 Jul 25; 136(1):58-64. PubMed ID: 18603054
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.